BOSTON SCIENTIFIC CORP — Form 10-Q
Filed November 2, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Michael F. Mahoney (CEO) and Jonathan Monson (CFO) certified Boston Scientific's Form 10-Q for the period ended September 30, 2026, filed November 2, 2026. Both officers certified that financial statements fairly present the company's financial condition and results of operations, and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or fraud involving management were disclosed.
Why this rating
Routine SOX 302/906 certification exhibits; standard periodic disclosure with no anomalies, deficiencies, or changes reported. Boilerplate compliance filing.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.